Live Breaking News & Updates on Cannabis Medical Sales

Stay updated with breaking news from Cannabis medical sales. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health


CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health
)
, an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named
Mentanine®, which has demonstrated at least
10-times (10X) the efficacy compared to Pharma Grade CBD.
Mentanine® - an
International CBD Excellence Award
2020 formulation was scientifically developed through preclinical trials at Western University. Results of its potential effect on anxiety, depression, PTSD, and schizophrenia
have been statistically significant. Our evidence also found that this formulation targeted a specific nuclear cellular receptor involved in anti-inflammatory mechanisms indicating that this formula may also treat inflammatory disorders. ....

United States , Steven Laviolette , Kostenloser Wertpapierhandel , Rob Rinderman , Paul Ramsay , International Patent , Company Or Canaquest , Biomedical Corp , Securities Exchange , Canaquest Co , Health Canada , Canaquest Medical Corp , University Ontario , Pharma Grade , Western University , Central Nervous System , Drug Identification Number , Quest Medical Corp , Master Formulations , Medical Corp , Cannabis Medical Sales , Export License , Post Traumatic Stress Disorder , Securities Act , Securities Exchange Act , Disclosure Statement ,

CanaQuest Medical Corp.: CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications


(0)
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the Company or CanaQuest )
, an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing a proactive investor relations and corporate communications program, further expanding investor community and media awareness about the company s material corporate developments and future prospects.
We are delighted that a seasoned communications professional with decades of financial experience has agreed to join our team at this important time in our corporate evolution, stated CanaQuest President Paul Ramsay. We believe adding a veteran like Rob to help us present our story to a wider and receptive audience is a key asset for us moving forward. ....

United States , Steven Laviolette , Kostenloser Wertpapierhandel , Rob Rinderman , Paul Ramsay , Company Or Canaquest , Biomedical Corp , American Stock Exchange , Canaquest Medical Corp , Health Canada , Stern School , Laviolette Western University , Canaquest President Paul , Wall Street , Western University , European Journal , Quest Medical Corp , Drug Identification Numbers , Master Formations , Medical Corp , Cannabis Medical Sales , Export License , Post Traumatic Stress Disorder , Canaquest Medical , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீவன் லாவிொலேத்தே ,